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A critical analysis of the surgical treatment of ﬁbroids compares all available techniques of myomectomy. Diﬀerent statistical
analyses reveal the advantages of the laparoscopic and hysteroscopic approach. Complications can arise from the location of the
ﬁbroids. They range from intermittent bleedings to continuous bleedings over several weeks, from single pain episodes to severe
pain,fromdysuriaandconstipationtochronicbladderandbowelspasms.Veryseldomdoesperitonitisoccur.Infertilitymayresult
from continuous metro and menorrhagia. The diﬃculty of the laparoscopic and hysteroscopic myomectomy lies in achieving
satisfactory haemostasis using the appropriate sutures. The hysteroscopic myomectomy requires an operative hysteroscope and a
well-experienced gynaecologic surgeon.
1.Introduction
In 25–30% of females, ﬁbroids are diagnosed. Although the
pathogenesis is not completely understood, we do know
that myomas are hormone dependent and are derived from
individual myoma cells and not from a metastatic process.
Myomas are the most common benign solid tumours of the
female genital tract. Although often asymptomatic, they may
cause menorrhagia, metrorrhagia, infertility, pain, pressure
symptoms haemorrhage, and repeated abortions. Whereas
open abdominal myomectomy results in limited morbidity,
similartothatwithhysterectomy,laparoscopicmyomectomy
has resulted in remarkable advantages for the patient in
medical, social, and economic terms, with less postoperative
painandshorterrecoverytime.SemmandMettlerpublished
their ﬁrst paper on laparoscopy myomectomy in 1980 [1].
Today, all myomas can be enucleated by this technique. Con-
ventional laparoscopic surgery is supplemented by robotic
support and abdominal entry often modiﬁed to NOS (natu-
ral oriﬁce surgery) and NOTES (natural oriﬁce transluminal
endoscopic surgery), also called single-port entry.
2.MaterialandMethods
Surgical Procedure
2.1. Conventional and Laparoscopic Myomectomy. According
to the extent of the ﬁbroid, the optic trocar is placed within
the umbilicus or 10cm higher up in the midline or at
Palmer’s point. Under vision 2-3 additional ports are placed
in the lower abdomen. The ﬁbroid resection technique varies
depending on the position and size of the myoma.
(1) Pedunculated Myomas. The pedicle of the myoma is
coagulated with bipolar forceps and cut with laparoscopic
scissors or resected after placement of loops or staplers.
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(2) Subserous and Intramural Myomas. After injection of
the ﬁbroid wall (extracapsular) with a vasopressin derivative
solution, an incision is made vertically or horizontally after
haemostasis with bipolar/monopolar forceps, ultrasound,
or thermofusion at the convex point of the uterus, at the
site of the underlying myoma and away from the adnexa.
The incision is extended until the pseudocapsule is reached;
the myoma dissection is then performed strictly within the
capsule plane using two pairs of grasping forceps. Con-
tinuous haemostasis is performed with the bipolar forceps
(ultracision). After myoma enucleation, the uterus is sutured
along a seromuscular plane (edge to edge) using one or two
layers of separate Poly Dioxanol Suture (PDS) stitches with
extra- or intracorporeal knots. The suture pedicles should
be within the wound. Continuous suction and irrigation are
performed to minimize adhesion formation.
The myomas are then extracted via the suprapubic route
by morcellation with an electric morcellator, followed by
a laparoscopic check and careful peritoneal cleansing and
haemostasis.
(3) Cervical Myomas. These myomas can be easily reached
and enucleated transvaginally; however, a combined vaginal
laparoscopic excision is sometimes necessary.
(4) Focal Adenomyosis. In cases of dysmenorrhoea resulting
from well-discernible adenomyotic lesions, careful enucle-
ation or resection of these areas is advised. Hysteroscopic
ultrasound assistance may guide the resection.
(5)SubmucousMyomas. Submucousmyomaslocatedwithin
theuterinecavityareclassiﬁedaccordingtotheirmyometrial
inﬁltration into 3 categories. The hysteroscopic resection of
these ﬁbroids is easy and is performed with the resectoscopic
loop in a slicing manner with bipolar or monopolar current.
(6) Hysteroscopy. Although the ﬁrst exploration of the
uterine cavity dates back to Bozzini, the modern CO2
liquid, oﬃce, and operative hysteroscopy (resectoscopy)
was developed by Hans Lindemann in Hamburg in 1972
and improved and modiﬁed by Bettocchi et al., Loﬀer
et al., Cooper et al., Gallinat, and Campo et al. [2–8].
Recently, vaginoscopy has again been applied to guide the
diagnostic hysteroscope from the vagina into the uterine
cervix without any traction of a cervical tenaculum. With
saline solution as the distension medium and under exact
pressure and ﬂow control, the visualization of the uterine
cavity and its pathology are visible, including the synechiae,
septum, endometrium, cervical canal, uterine cavity with
uterine ostia, polyps, and ﬁbroids. The most modern system
oﬀers continuous suction of resected material. The ESHRE
classiﬁcation of 1993 makes it easier to describe the location
of the ﬁbroid [5, 9].
2.2.Single-PortMyomaEnucleation. Myomaenucleationcan
easily be performed via all kinds of single-port entries (SILS:
single incision laparoscopic surgery, LESS: laparo-endoscop-
ic single-site surgery), natural oriﬁce surgery (NOS), and
natural oriﬁce transluminal endoscopic surgery (NOTES).
The problem, however, lies in the morcellation of the mate-
rial and the extraction. The answer might be found in homo-
genization to powder.
2.3. Robotic Myomectomy. Once the learning curve is over,
the da Vinci robot oﬀers a more precise technique for every
surgery, including myomectomies. Robotic suturing is easier
andfaster.Inmyopinion,onedayallsurgicalprocedureswill
be performed robotically.
After 30 years of experience in performing and teaching
laparoscopic myomectomies, Professor Mettler has had the
opportunity to perform a number of robotically assisted my-
omectomies with the da Vinci robot. The procedure is easily,
can be, performed with less blood loss than at laparoscopy,
and suturing can be carried out more precisely. However,
three-dimensional vision and articulated instruments may
also serve the same purpose. Robotic surgery is fascinating,
but a ﬁnancial revolution would have to occur for it to be
accepted throughout the world, not only for cancer surgery
b u ta l s of o rp r o c e d u r e ss u c ha sm y o m e c t o m y .
2.4. Laparotomic Myomectomy. A laparotomic myomectomy
may be performed if the myoma is >20cm in diameter,
located at a very critical point, or suspected of being a
sarcoma. More than 10 ﬁbroids may require a laparotomy.
The decision is taken by the surgeon.
2.5. Hysterectomy
(1)ClassicIntrafascialSupracervicalHysterectomy(CISH). In
cases of adenomyosis or diﬀuse myomatosis of the uterus
with no cervical pathology, CISH or LASH should be the
method of choice for hysterectomy [10]. At CISH, the
transformation zone of the cervix is cored out in addition
to the subtotal uterine resection.
(2) Laparoscopic Subtotal Hysterectomy (LASH). LASH has
proved to be a safe, quick, and very atraumatic hysterectomy
technique. The advantage of the LASH procedure is that it
can be performed on nulliparous patients, patients who have
not previously had a vaginal delivery, and patients who have
had previous abdominal surgery. In these cases, the uterus is
morcellated, but no colpotomy is performed.
(3) Total Laparoscopic Hysterectomy (TLH). Indications for
TLH include benign gynaecological alterations such as
ﬁbroids, endometriosis, and dysfunctional uterine bleeding
in patients for whom vaginal surgery is contraindicated or
cannot be performed. TLH may be performed for possible
malignant indications such as early endometrial cancer, early
localized small cervical cancers (trachelectomy), and also in
the early stages of ovarian cancer with lymphadenectomies.
The laparoscopic part consists of preparation of the uterus,
the cervix, and complete dissection of the vaginal stump.
(4)VaginalHysterectomy. When Langenbeck ﬁrst performed
a vaginal hysterectomy in 1813, the discipline of gynaecology
was founded. Since then vaginal access has been the priv-
ilege of the gynaecological surgeon. In 1939, according toObstetrics and Gynecology International 3
the French surgical expert Doyen, no one could call himself a
gynaecologistifhehadnotperformedavaginalhysterectomy
[11].
V a g i n a lh y s t e r e c t o m yi ss t i l lac e n t r a lf e a t u r eo fg y n a e -
cological discussion. The gynaecologist only considers other
access routes for the exploration of the minor pelvis if
vaginal access cannot give a clear diagnosis and possibility
oftreatment.Today,however,itappearsthatonlyveryskilled
vaginalsurgeonsstilloperateonﬁbroidsviathevaginalroute
using vaginal morcellation with a knife.
(5)AbdominalHysterectomy. Abdominalhysterectomytoday
is a safe technique. There is no more fear of infection,
thrombosis, or other morbidities. In the last 40 years of
the 20th century, an explosive increase in the number of
hysterectomies took place. Even in Germany, the method
of choice for bleeding abnormalities, myomas, and other
pathology was always laparotomy and hysterectomy. Large
diﬀuse ﬁbroids and multiple ﬁbroids still sometimes require
an abdominal hysterectomy.
2.6. Adhesion Prevention. Under the multitude of adhesion,
prevention agents presented over the last 10 years, Adept
(4% icodextrin solution) hyalobarriers and SprayShield (a
polyethylene glycol sprayable liquid that polymerizes within
seconds to a hydroabsorbable gel) appear to be the most
promising substances. Hya-Corp endogel, an antiadhesion
gel on hyaluronidase basis, is also highly recommended.
2.7. Haemorrhage. Haemorrhage can occur in submucous
ﬁbroids although seldom in intramural ﬁbroids. The only
therapy is myomectomy, no further discussion is necessary.
3. Results
3.1. Comparison of Removal of Single and Multiple Fibroids.
From January 2002 till September 2007, 335 women, with
a mean age of 35.2 years, underwent single or multiple
intracapsular laparoscopic myomectomy in multiple gynae-
cological centers. Of these patients, 62 had undergone a
previous caesarean section (18.7%). All patients signed
an informed consent prior to inclusion in this study, as
approvedbythelocalinstitutionalresearchethicscommittee.
The selected patients requested a myomectomy for the
following associated symptoms: pelvic pain, menorrhagia,
and growth of myomatic nodules, as veriﬁed by ultrasound.
Af e wr e q u e s t e dm y o m e c t o m yi nv i e wo faf u t u r ep r e g n a n c y .
Exclusion criteria for the investigation were as follows: pre-
vious uterine surgery (excluding caesarean section), presur-
gical treatment with GnRH analogs, a history of gynaecolog-
ical malignancy, and primary subfertility.
Exclusion criteria for preoperative GnRH analog treat-
ment were due to reported increased risk of recurrence, a
possible delay in the diagnosis of leiomyosarcoma, a risk
of massive hemorrhage from degeneration, a greater diﬃ-
culty in ﬁnding the cleavage plane, and a greater extent of
hyalinization phenomena [12, 13]. All ﬁbroids were selected
through standardized transvaginal ultrasound myoma map-
ping; all patients had subserous and/or intramural ﬁbroids,
andtransvaginalultrasounddateswererecordedforpostsur-
gical evaluation.
In the preliminary study setup, clinicians selected all
women who had 3–6 myomas as patients to be submitted to
multiple myomectomy. In the study setting, the size of the
myoma before laparoscopy was between 4 and 9cm. This
limit was selected by surgeons to avoid longer operation
times and pointless uterine trauma for smaller ﬁbroids.
To give homogeneity to the intracapsular laparoscopic
myomectomy, the authors excluded pedunculated, cervi-
cal, and intraligamentary myomas because they are extra
myometrium.
Patients were ﬁrst subdivided into two nonrandomized
groups: 195 women with a single myoma in group I and 140
with two or more myomas (less than four) in group II.
The women underwent a standardized technique,
described by Mais et al. in 1996, which was performed by the
same well-trained residents in referred gynecological centers
[14]. This standardized technique involved hysterotomy,
pseudocapsule incision, extracting the myoma by stretching
and uterine suturing.
Before incising the myometrium covering the myoma,
a 10cc solution of vasopressin or diluted adrenalin (1/100)
was injected into the tissue layers, to make tissue ischemia
easier and better delineate the cleavage plane and the
pseudocapsule.
The laparoscopic intracapsular myomectomy was per-
formed using the following intracapsular technique: the
myometrium was incised vertically using a monopolar
scalpel after identifying the plane between the pseudocapsule
and the myoma.
The purpose of hysterotomy, with regard to the length
and depth of the uterine incisions, was to expose the myoma
pseudocapsule. Thus, the depth of the uterine incision was
adapted to localize ﬁbroids in the uterus and to show the
surrounding structure. The length of the incision was, on
average, based on the ﬁbroid diameter. Generally, the length
in each group was limited to the length of the myoma
downside, and the depth of the uterine incision was limited
to the depth of the pseudocapsule.
To dissect the pseudocapsule connective bridges from
the surrounding myometrium and to allow the enucleation
of the intracapsular myoma, the authors used a monopolar
crochet needle or bipolar clamp-scissors (Gyrus PlasmaKi-
netic AMS) and myoma drills or Collins forceps (Figure 1).
In all procedures, myomas were removed using electrical
morcellators (Karl Storz Endoscopy and Gynecare, John-
son & Johnson), and the myometrium was sutured using
intra- and extracorporeal single or double stitches, with 0
absorbable poliglecaprone monoﬁlament.
Surgeons approximated the clear edges of the uterine
defect (linked to intracapsular method), with introﬂexing
single U-stitches, at 1cm increments. If the myometrial
defect was deep or large, it was repaired by suturing with
multiple intro-ﬂexing single stitches, followed by serosal
repair with multiple introﬂexing single stitches. Albeit dif-
ﬁcult, at times the myometrium required two-layer suturing.4 Obstetrics and Gynecology International
(a) (b) (c)
Figure 1: Myomectomy: (a) intraoperative sight of the myoma and its surrounding vascularized capsula. (b) Reconstruction of the uterine
wall after excision of the tumor. (c) Removing the myoma by morcellation.
Table 1: Baseline characteristics of the study participants.
Group I Group II P value
195 patients 140 patients
Age, years
(mean ± SD)
34.9 ± 2.9 (range,
26–48)
35.6 ± 3.8 (range,
23–50) P>0.05
BMI (mean ±
SD) 21.8 ± 1.7 22.9 ± 1.3 P>0.05
Parity (mean ±
SD) 1.2 ± 0.3 1.3 ± 0.9 P>0.05
Sutureswerethenappliedat1cmincrements,usingextra-or
intracorporeal adequate knot tying, depending on bleeding:
extracorporeal for larger bleeding and intracorporeal for
smaller.
A standard transvaginal ultrasonography detected prob-
lemsbeforedischargellprocedureswerebasedonthefollow-
ing surgical parameters: inﬁltration into the myometrium
(number of patients per group), total operating time (in
minutes), intrasurgical blood loss (in mL), postsurgical
bleeding (mL in drainage), need for painkiller drugs (num-
ber of patients per group), postoperative fever (number of
patients with fever >38◦C after 24 hours and for the ﬁrst 2
days of hospitalization), postoperative antibiotic administra-
tion (number of patients who requested therapy), duration
of hospitalization (for 24 or 48 hours), and postoperative
clinically signiﬁcant intramyometrial hematoma >3cm, as
detected by a standard transvaginal ultrasonography before
discharge [15].
The symptoms of patients submitted to laparoscopic
myomectomy in group I were pelvic pain in 134 patients
(68.7%), menorrhagia in 91 patients (46.6%), and growth
of myomatic nodules, conﬁrmed by ultrasound (US), in 119
(61.02%). In group II, the same symptoms were reported by
59 (42.1%), 77 (55%), and 73 patients (52.1%), respectively.
Acomparisonofparticipants’baselinecharacteristicsdid
not show any statistically signiﬁcant diﬀerences (P<0.05)
(Table 1).
The mean total laparoscopic operating time was 60 ±
7.2 minutes in group I and was signiﬁcantly longer in group
II with 97 ± 8.9m i n u t e s( P<0.05 in the Student’s t-test
analysis). No statistical diﬀerences (P>0.05) were found in
the amount of mean intraoperative blood loss (140 ±4.7mL
in group I versus 175 ± 6.8 in group II), the number of
catheters placed inside the pelvis for postsurgical drainage
(78 women in group I versus 51 in group II), the need for
painkillers (81 women in group I versus 56 in group II),
postoperative fever on 1st hospitalization day (22 patients in
group I versus 13 in group II), or postoperative antibiotic
administration (16 women in group I versus 9 in group
II). In the Student’s t-test analysis, no statistical diﬀerences
(P>0.05) were found for the duration of hospitalization
with respect to the number of women discharged in 24 hours
(140 women in group I versus 99 in group II) and in 48
hours (55 patients in group I versus 41 in group II) or in
the detection of postoperative intramyometrial hematoma
(>3cm) with ultrasound during the patients’ hospitalization
( 1 3w o m e ni ng r o u pIv e r s u s8i ng r o u pI I ) .
No laparoconversion was performed in this study. Nor-
mally, all patients leave the operating theater with an anal-
gesic mixture of ketorolac or tramadol in pump; however,
if patients request more analgesic, nurses are accustomed
to administer “on demand” 30mg ketorolac i.v. or 100mg
tramadol i.v. in allergic patients (Table 2).
There were no signiﬁcant diﬀerences in short-term com-
plications,suchasacuteanaemia(withHb<9g/dL,hemato-
crit (Hct) < 30 or red cells (RC) < 3,500,000 millions/mm3),
postoperative excessive abdominal bleeding (more than
50mL of blood in the catheter inside the pelvis for post-
surgical drainage), and urinary tract infections (detected by
positive urine culture after Foley removal) between the two
groups (Table 3).
All women became pregnant spontaneously, without
assisted fertility techniques or pharmacological preconcep-
tion treatments for subfertility, and none of the remaining
patients decided to receive additional assisted reproductive
technology (ART).
3.2. Spontaneous Pregnancy Rate after Laparoscopic
Myomectomy in Kiel. In a series of 1032 laparoscopic myo-
mectomies, there were only 6 complications (Kiel University
Department of Obstetrics and Gynaecology, Germany).
Out of 130 patients desiring pregnancies, 78 (60%) became
pregnant. Among the 78 pregnancies, there were 6 abortions,
60 spontaneous deliveries, and 18 caesarean sections. Eight
sets of twins and one set of triplets were reported [16].Obstetrics and Gynecology International 5
Table 2: Myoma and surgical procedure outcome of the study participants.
Group I Group II P value
195 patients 140 patients
Inﬁltration of myometrium (no. of patients) 18 (17.6%) 10 (14.9%) >0.05
Total operative laparoscopic time (minutes) 60 ± 7.2 (53–67) 97 ± 8.9 (89–105) <0.05
Intrasurgical blood loss (mL) 140 ± 4.7 (135–145) 175 ± 6.8 (168–182) >0.05
Catheter inside pelvis for postsurgical drainage (no. of patients) 78 (40%) 51 (36.4%) >0.05
Need for painkiller drugs (no. of patients) 81 (41.5%) 56 (40%) >0.05
Fever (no. of patients with fever > 38◦C after 24 hours and for
the ﬁrst 2 days of hospitalization) 22 (11.2%) 13 (9.2%) >0.05
Therapeutic postoperative antibiotics administration (no. of
patients) 16 (8.2%) 9 (6.4%) >0.05
Duration of hospital stay: discharging in 24 hours (no. of
patients) 140 (71.7%) 99 (70.7%) >0.05
Duration of hospital stay: discharging in 48 hours (no. of
patients) 55 (28.2%) 41 (29.2%) >0.05
US hematoma (>3cm) detected in myometrium (no. of
patients) 13 (6.6%) 8 (5.7%) >0.05
Data are presented as mean ± standard deviation or median range.
Table 3: Short-term complications after laparoscopic intracapsular myomectomy.
Group I Group II P value
195 patients 140 patients
Hemoglobin preoperative (range in g/dL) 11.8 ± 2.8 12.1 ± 1.6 >0.05
Hemoglobin postoperative (range in g/dL) 10.4 ± 1.7 11.2 ± 1.9 >0.05
Hematocrit preoperative (range in %) 36.3 ± 3.9 36.8 ± 4.7 >0.05
Hematocrit postoperative (range in %) 33.2 ± 5.6 32.9 ± 8.1 >0.05
Red cells preoperative (range in milions/mm3) 4209 ± 227.2 4324 ± 235.1 >0.05
Red cells postoperative (range in milions/mm3) 4120 ± 193.4 3990 ± 235.3 >0.05
Postoperative blood collection in the catheter inside
pelvis (range in mL) 41 ± 5.3 38 ± 9.3 >0.05
Postoperative bladder pain after foley removal (no. of
patients) 10 ± 6.4 9 ± 5.2 >0.05
3.3. Update on Laparoscopic Myomectomies and Hysteroscopic
Treatment. In laparoscopic myomectomy, the types of my-
oma treated were as follows: pedunculated-subserous 24%,
intramural 76%, and diﬀu s em y o m a t o s i s0 %( Figure 2). The
average diameter of the myomas excised laparoscopically was
4 ± 2.1cm (range 1–10cm), with 57% having a diameter
>4cm. A drain to observe possible intraabdominal bleeding
was placed in 168 laparoscopic myomectomy cases and
removed after 24h. No patient required a blood transfusion.
The mean operating time for laparoscopic myomectomy
was 90min (range 25–215min). The mean length of hos-
pitalization for laparoscopic myomectomy was 2 ± 0.5d a y s
(range 2–6 days). In Germany at the time the study was
carried out, the hospital was paid by insurance companies
according to the number of days the patient was hospitalized
and not according to the procedure performed. This resulted
in longer hospital stays. This practice is now changing.
4. Patient Outcomes
4.1. Immediate Complications/Late Complications. Two pa-
tients had hematoma formation within the abdominal wall.
In one patient, the epigastric artery was stitched imme-
diately; in the second, patient a growing haematoma was
found in the left abdominal wall four hours later. No late
complications, such as bleeding, urinary tract infections, or
bowel lesions, occurred.
4.2. Multiple Fibroids and Need for Subsequent Surgery. Six to
eight weeks later, a second-look laparoscopy with myomec-
tomy was suggested for seven of the 178 patients who
had undergone laparoscopic myomectomy. The individual
surgeon decided in each case to operate in two sessions.
No conversions to laparotomy occurred. In our department,
patients with larger ﬁbroids undergo a mini-laparotomy/ﬁ-






















Figure 2: Types of myomas according to their type of surgery lap-
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Figure3:Incidenceofmyomasrelatedtoparityinlaparoscopicmy-
omectomies.
patients had only one myoma, either pedunculated-subse-
rous or intramural (Figure 4).
4.3.ReliefofSymptoms. Todate,ofthe178patients,onlytwo
had further surgery for complaints associated with bleeding
abnormalities and the need for hysterectomy.
5. FertilityOutcome
The nulliparous women had the highest number of myomas,
and the least were found in women who were para >3
(Figure 3). When the selection criteria were strictly adhered
to, and there was no other associated infertility, laparoscopic
myomectomy increased implantation rates [17, 18].
Over a period of 10 months to 4 years postlaparoscopic
myomectomy, a 55% pregnancy rate was achieved. The
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Figure 4: Number of pedunculated sub serous myomas (n = 42) in
laparoscopic myomectomy.
Laparoscopic myomectomy allows a safe vaginal delivery
[19–21]. Other possible techniques are the embolization of
uterine arteries or laparoscopic uterine artery ligation [22].
Patients who have undergone laparoscopic or laparo-
tomic myomectomy and become pregnant should inform
their gynecologists in case a caesarean section should be
necessary.
6. Postoperative Resumption of Normal Life
Patients treated by laparoscopic myomectomy returned to
work within 4–6 days after the initial surgery.
7. Discussion
7.1. Advantages of Laparoscopic Myomectomy over Open
Myomectomy. In a literature search using Medline, 1400
citations were found. Selected papers were screened for
further references. Criteria for selection of literature were
the number of cases (excluded if less than 20), methods of
analysis (statistical or non-statistical), operative procedure
(only universally accepted procedures were selected), and the
institutionwherethestudywasdone(specializedinstitutions
for laparoscopic surgery) [23]. Out of a total of 30 articles,
only six met the selection criteria.
Chapron et al., in a 2002 meta-analysis of published
data from randomized clinical trials, looked at risks facing
patients after laparoscopic myomectomy (1809 patients
underwent laparoscopy and 1802 patients laparotomy) [24].
They found that the overall risk of complications was
signiﬁcantly lower for patients operated by laparoscopy [24].
Holzer et al. are accredited with the ﬁrst double-blind
study in pain control after laparoscopic myomectomy [25].
After surgery, all the patients had similar dressings and
therefore none of the patients knew who had undergone
which type of surgery (19 had laparoscopy and 21 had
laparotomy). The investigators were also kept in the dark.
Analysis done on completion of the study showed that
laparoscopic surgery had clear advantages over laparotomy
as far as pain control is concerned [25].Obstetrics and Gynecology International 7
Rossetti et al., in their review published in April 2001,
looked at the rate of myoma recurrence following either
laparoscopic or laparotomic myomectomy (162 patients, 82
for each type of surgery) [26]. Patient followup continued
for up to 40 months. At the end of this time, 11 in the
laparoscopy and 9 in the laparotomy group had suﬀered a
recurrence. Analysis did not show any statistical signiﬁcance
[26].
To evaluate our own laparoscopic myomectomies, let us
present our most recently evaluated series of 178 myomec-
tomies in Kiel [16].
T h ef o l l o w i n gﬁ v ec r i t e r i aw e r ee v a l u a t e di naq u e s -
tionnaire sent to all patients 10–24 months after surgical
treatment: (1) immediate or late complications, (2) need for
next, repeat or subsequent second-look surgery, (3) relief
of symptoms, (4) fertility outcome, and (5) resumption of
normal life.
7.1.1. Signs and Symptoms of Myomas. Of the 178 patients,
24% had a pelvic mass with pressure symptoms, 17%
metrorrhagia, 14% pelvic pain, and 40% infertility.
7.1.2. Immediate Complications/Late Complications. Two
patients had haematoma formation within the abdominal
wall. In one patient, the epigastric artery was lacerated
and stitched immediately; in the second patient a growing
haematoma was found in the left abdominal wall four hours
later. No late complications, such as bleeding, urinary tract
infections, or bowel lesions, occurred. The incidence of
myomas related to parity: 97 = 55% were nulliparous, 11 =
6% para 3, and > 3.68 = 39% para 1 and 2.
7.2. Complications and Conclusion. Complications can arise
from the location of the ﬁbroids. These complications range
from intermittent bleedings to continuous bleeding over
weeks, from single pain episodes to severe menorrhagia
and chronic abdominal pain with intermittent spasms, from
dysuria and constipation to chronic bladder and bowel
spasms and even to peritonitis. Infertility may be the result
of continuous metro and menorrhagia, leading to chronic
infection and uterine spasms up to nonimplantation. Possi-
blecomplicationsresultingfromtreatmentofthesedisorders
are haemorrhages, infection, adhesions, and secondary pain
resulting from the treatment eﬀorts.
Uterine myomas are very common in women of repro-
ductive age and their diagnosis does not always require
surgery. With the introduction of GnRH analogs medical
treatment has become feasible. This medical treatment is
capable of inducing a substantial reduction in the volume of
the myoma (up to 50%) by reducing circulating oestrogen
levels. Maximum reduction is achieved by a twelve-week
therapy. However, after cessation of therapy, the myoma can
again increase its size, up to the initial diameter, within
three months. Myomas may be responsible for metrorrhagia,
pelvic pain, anaemia, infertility, and abortion. When these
symptoms occur, primary treatment might be analgesics for
pelvic pain, iron for anaemia, or even IVF for infertility.
However, if this treatment is unsuccessful, surgery is always
indicated [27–29].
When surgery is indicated in cases of myomas, laparo-
scopic surgery is the primary choice. Depending on the
alternatives available to the surgical team, the endoscopic
treatment may be conventional laparoscopic, robotic, resec-
toscopic, using single or multiple ports with NOS or NOTES
or hysteroscopic, according to the location.
Preoperative assessment is important to determine the
operative strategy according to size, number, and location
of the myomas. Precise preoperative diagnosis indicates
whether laparoscopic myomectomy is possible or whether
laparotomy should be performed for large or numerous
myomas. Each approach has its own indications.
The results of our study and many international series
demonstrate the feasibility of laparoscopic and hysteroscopic
myomectomy as a technique leading to remission of symp-
toms and a low rate of complications. The diﬃculty of the
operation lies in achieving satisfactory haemostasis and an
appropriate usage of sutures. The hysteroscopic myomec-
tomy requires an operative hysteroscope and a well-trained
gynaecological surgeon to use it [30]. Severe haemorrhages
can be tackled and adhesions can be prevented.
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